Safety and Efficacy Study Comparing 3 New Types of Coronary Stents

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2291 participants.

Also called NCT01166685

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,291 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01166685
Other papers using this trial's data
  • Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial Circulation, 2015-01-06 DOI, PubMed 25411159

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, Denmark, Germany, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01166685. Randomized; no masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2014-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Study Comparing 3 New Types of Coronary Stents
Condition
Coronary Thrombosis
Intervention (Device)
Everolimus-eluting stent
Intervention (Device)
Bare-metal stent
Intervention (Device)
Biodegradable Polymer-DES
Lead sponsor
University Hospital, Basel, Switzerland (class: other)

Record details

Record id
cardio:ct-nct01166685
Content hash
e5aef25246eeb59f9f50986a49fc2cd12d6455270b72e45ee295f9cf589e747e